Insoluble Drug Formulation

Extended In Vivo Half Life

Improved Efficacy

Higher Dosage to Target Organ

Biological Properties

Drug Conc. Fungal Counts

2.7

3.0

3.6

16.5

97

160

87

13

Original Formulation

Drug Conc. Fungal Counts

5.0

11.8

24.5

47.4

9

5

0

0

Nanoedge Formulation

Previous slide

Next slide

Back to first slide

View graphic version